Hadara Rubinfeld

1.7k total citations
27 papers, 1.3k citations indexed

About

Hadara Rubinfeld is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Epidemiology. According to data from OpenAlex, Hadara Rubinfeld has authored 27 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 11 papers in Endocrinology, Diabetes and Metabolism and 8 papers in Epidemiology. Recurrent topics in Hadara Rubinfeld's work include Neuroendocrine Tumor Research Advances (8 papers), Protein Kinase Regulation and GTPase Signaling (7 papers) and Pituitary Gland Disorders and Treatments (7 papers). Hadara Rubinfeld is often cited by papers focused on Neuroendocrine Tumor Research Advances (8 papers), Protein Kinase Regulation and GTPase Signaling (7 papers) and Pituitary Gland Disorders and Treatments (7 papers). Hadara Rubinfeld collaborates with scholars based in Israel, Germany and United States. Hadara Rubinfeld's co-authors include Rony Seger, Tamar Hanoch, Ilan Shimon, Hanna Jaaro, Moshe Hadani, Simona Grozinsky‐Glasberg, Zvi R. Cohen, Günter K. Stalla, Marily Theodoropoulou and Zhong Yao and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Hadara Rubinfeld

27 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hadara Rubinfeld Israel 18 780 236 226 218 164 27 1.3k
Mateus T. Guerra United States 20 809 1.0× 129 0.5× 144 0.6× 219 1.0× 238 1.5× 32 1.4k
Tracey L. Fisher United States 12 1.3k 1.6× 204 0.9× 210 0.9× 98 0.4× 144 0.9× 17 1.7k
Koji Nata Japan 28 781 1.0× 199 0.8× 377 1.7× 121 0.6× 191 1.2× 52 2.6k
Isabelle Pirson Belgium 25 1.1k 1.4× 377 1.6× 193 0.9× 56 0.3× 258 1.6× 57 1.6k
Christopher J. Caunt United Kingdom 25 1.5k 2.0× 173 0.7× 317 1.4× 97 0.4× 246 1.5× 40 2.3k
Yasunobu Uchijima Japan 22 1.3k 1.6× 180 0.8× 114 0.5× 181 0.8× 514 3.1× 41 1.9k
L. S. P. Davidson United Kingdom 24 1.1k 1.5× 89 0.4× 169 0.7× 76 0.3× 166 1.0× 50 1.6k
Sui Wang United States 22 1.1k 1.4× 184 0.8× 89 0.4× 119 0.5× 121 0.7× 52 1.7k
Carol L. Sable United States 12 1.3k 1.6× 113 0.5× 242 1.1× 75 0.3× 161 1.0× 14 1.7k
Laura R. Pearce United Kingdom 8 1.6k 2.1× 76 0.3× 188 0.8× 146 0.7× 309 1.9× 9 2.1k

Countries citing papers authored by Hadara Rubinfeld

Since Specialization
Citations

This map shows the geographic impact of Hadara Rubinfeld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hadara Rubinfeld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hadara Rubinfeld more than expected).

Fields of papers citing papers by Hadara Rubinfeld

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hadara Rubinfeld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hadara Rubinfeld. The network helps show where Hadara Rubinfeld may publish in the future.

Co-authorship network of co-authors of Hadara Rubinfeld

This figure shows the co-authorship network connecting the top 25 collaborators of Hadara Rubinfeld. A scholar is included among the top collaborators of Hadara Rubinfeld based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hadara Rubinfeld. Hadara Rubinfeld is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Shimon, Ilan, et al.. (2022). PICT ‐1 regulates p53 splicing and sensitivity of medullary thyroid carcinoma cells to everolimus. Journal of Neuroendocrinology. 34(10). e13187–e13187. 1 indexed citations
3.
Cohen, Zvi R., et al.. (2019). Antibody array strategy for human growth factor secretome profiling of GH-secreting adenomas. Pituitary. 22(4). 344–352. 1 indexed citations
4.
Rubinfeld, Hadara, et al.. (2015). Combination of mTOR Inhibitors Augments Potency while Activating PI3K Signaling in Pituitary Tumors. Neuroendocrinology. 103(5). 592–604. 4 indexed citations
5.
Rubinfeld, Hadara, Alexander Gorshtein, Zvi R. Cohen, et al.. (2014). IGF1 induces cell proliferation in human pituitary tumors – Functional blockade of IGF1 receptor as a novel therapeutic approach in non-functioning tumors. Molecular and Cellular Endocrinology. 390(1-2). 93–101. 9 indexed citations
6.
Rubinfeld, Hadara & Ilan Shimon. (2012). PI3K/Akt/mTOR and Raf/MEK/ERK signaling pathways perturbations in non-functioning pituitary adenomas. Endocrine. 42(2). 285–291. 28 indexed citations
7.
Grozinsky‐Glasberg, Simona, Ilan Shimon, & Hadara Rubinfeld. (2012). The Role of Cell Lines in the Study of Neuroendocrine Tumors. Neuroendocrinology. 96(3). 173–187. 49 indexed citations
8.
Rubinfeld, Hadara, Victoria Cohen‐Kaplan, Dvora Nass, et al.. (2011). Heparanase Is Highly Expressed and Regulates Proliferation in GH-Secreting Pituitary Tumor Cells. Endocrinology. 152(12). 4562–4570. 15 indexed citations
9.
Garcia, Jose Luis Monteserin, Hadara Rubinfeld, Michael Buchfelder, et al.. (2010). The Somatostatin Analogue Octreotide Confers Sensitivity to Rapamycin Treatment on Pituitary Tumor Cells. Cancer Research. 70(2). 666–674. 84 indexed citations
10.
Gorshtein, Alexander, Hadara Rubinfeld, Marily Theodoropoulou, et al.. (2009). Mammalian target of rapamycin inhibitors rapamycin and RAD001 (everolimus) induce anti-proliferative effects in GH-secreting pituitary tumor cells in vitro. Endocrine Related Cancer. 16(3). 1017–1027. 65 indexed citations
11.
Grozinsky‐Glasberg, Simona, Hadara Rubinfeld, Alexander Gorshtein, et al.. (2009). The rapamycin-derivative RAD001 (everolimus) inhibits cell viability and interacts with the Akt–mTOR–p70S6K pathway in human medullary thyroid carcinoma cells. Molecular and Cellular Endocrinology. 315(1-2). 87–94. 31 indexed citations
12.
Padova, Hagit, Hadara Rubinfeld, Moshe Hadani, et al.. (2007). Effects of selective somatostatin analogs and cortistatin on cell viability in cultured human non-functioning pituitary adenomas. Molecular and Cellular Endocrinology. 286(1-2). 214–218. 17 indexed citations
13.
Segal‐Lieberman, Gabriella, et al.. (2006). Melanin-concentrating hormone stimulates human growth hormone secretion: a novel effect of MCH on the hypothalamic-pituitary axis. American Journal of Physiology-Endocrinology and Metabolism. 290(5). E982–E988. 18 indexed citations
14.
Rubinfeld, Hadara & Rony Seger. (2005). The ERK Cascade: A Prototype of MAPK Signaling. Molecular Biotechnology. 31(2). 151–174. 375 indexed citations
15.
Rubinek, Tamar, Hadara Rubinfeld, Moshe Hadani, Gad Barkai, & Ilan Shimon. (2005). Nitric Oxide Stimulates Growth Hormone Secretion from Human Fetal Pituitaries and Cultured Pituitary Adenomas. Endocrine. 28(2). 209–216. 22 indexed citations
16.
Brodie, Chaya, Gila Kazimirsky, Hadara Rubinfeld, et al.. (2004). PKCδ Associates with and Is Involved in the Phosphorylation of RasGRP3 in Response to Phorbol Esters. Molecular Pharmacology. 66(1). 76–84. 40 indexed citations
17.
Rubinfeld, Hadara & Rony Seger. (2004). The ERK Cascade As a Prototype of MAPK Signaling Pathways. Humana Press eBooks. 250. 1–28. 54 indexed citations
18.
Rubinfeld, Hadara, Moshe Hadani, Divino Deoliveira, et al.. (2004). Novel ghrelin analogs with improved affinity for the GH secretagogue receptor stimulate GH and prolactin release from human pituitary cells. European Journal of Endocrinology. 151(6). 787–795. 26 indexed citations
19.
Rubinfeld, Hadara & Rony Seger. (1998). Detection of MAP Kinase Signaling. Current Protocols in Cell Biology. 0(1). 2 indexed citations
20.
Yung, Yuval, Zhong Yao, Hadara Rubinfeld, et al.. (1997). Detection of ERK activation by a novel monoclonal antibody. FEBS Letters. 408(3). 292–296. 121 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mateus T. Guerra Breakdown of academic impact, for papers by Tracey L. Fisher Breakdown of academic impact, for papers by Koji Nata Breakdown of academic impact, for papers by Isabelle Pirson Breakdown of academic impact, for papers by Christopher J. Caunt Breakdown of academic impact, for papers by Yasunobu Uchijima Breakdown of academic impact, for papers by L. S. P. Davidson Breakdown of academic impact, for papers by Sui Wang Breakdown of academic impact, for papers by Carol L. Sable Breakdown of academic impact, for papers by Laura R. Pearce
Rankless by CCL
2026